Cambridge Cognition Holdings PLC (COG) · 2026-10-06

COG joins Imperial College-led NHS Study

Cambridge Cognition has joined an NHS study evaluating CANTAB with blood biomarkers; the 15-month, 500-participant project offers no disclosed revenue.

Cambridge Cognition Holdings plc (COG) · 2026-09-21

Partnership with C2N and The Alzheimer's Trust

Cambridge Cognition has partnered with C2N Diagnostics and The Alzheimer's Trust to make its CANTAB Pathway available in an integrated UK Alzheimer's diagnostic pathway. UK healthcare professionals can now order the platform through The Alzheimer's Trust.

Cambridge Cognition Holdings PLC (COG) · 2026-09-16

Interim Results

Cambridge Cognition flagged material uncertainty over its ability to continue as a going concern: it must generate cash from new sales orders and may need cost savings or fundraising. Operating losses narrowed to £0.6m and July fundraising raised £2.6m before expenses.

Cambridge Cognition Holdings Plc (COG) · 2026-06-30

Result of Retail Offer

Cambridge Cognition said its Retail Offer launched on 24 June 2026 has now closed, raising gross proceeds of approximately GBP48,000. It has conditionally raised total gross proceeds of approximately GBP2.59 million across the Placing, Subscription and Retail Offer.

Cambridge Cognition Holdings plc (COG) · 2026-06-24

Retail Offer

Cambridge Cognition has launched a retail offer at 35.0p a share. The deal is conditional on the placing and subscription completing, with admission of new shares expected on 13 July 2026.

Cambridge Cognition Holdings Plc (COG) · 2026-06-24

Result of Placing & Posting of Circular

Cambridge Cognition has conditionally raised about £2.54m before expenses at 35.0p a share. It is also running a retail offer for up to £0.5m, with admission of the new shares expected on 13 July 2026 if shareholders approve the deal.